These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: Xamoterol activates beta 1- but not beta 2-adrenoceptors in mammalian myocardium: comparison of its affinity for beta 1- and beta 2-adrenoceptors coupled to the adenylate cyclase in feline and human ventricle with positive inotropic effects. Author: Lemoine H, Bilski A, Kaumann AJ. Journal: J Cardiovasc Pharmacol; 1989 Jan; 13(1):105-17. PubMed ID: 2468921. Abstract: The mode of action of xamoterol, a beta 1-selective partial agonist, was investigated in feline myocardium. Xamoterol bound with an 18-fold greater affinity to ventricular beta 1-adrenoceptors (labeled with [3H](-)-bisoprolol) than to beta 2-adrenoceptors (labeled with [3H]ICI 118,551). Xamoterol had a 10-20-fold higher affinity for ventricular beta 1-adrenoceptors coupled to the adenylate cyclase than for cyclase-coupled beta 2-adrenoceptors. The intrinsic activity of xamoterol with respect to (-)-norepinephrine was 0.5 in right ventricular papillary muscles (force), 0.6 in left atria (force); 0.6 in right atria (sinoatrial rate) and 0.1-0.2 in ventricular membranes (cyclase). The stimulant effects of xamoterol were antagonized by beta 1-specific CGP 20,712 A but not by beta 2-selective ICI 118,551. Xamoterol activated only beta 1-adrenoceptors, while beta 2-adrenoceptors occupied by xamoterol remained silent. The positive inotropic effects of a nearly maximally effective xamoterol concentration were associated with a considerably greater beta 1-mediated cyclase stimulation than the same inotropic effect of (-)-norepinephrine. In human ventricular membranes xamoterol stimulated marginally the adenylate cyclase and antagonized the effects of (-)-norepinephrine with a 30-fold greater affinity for beta 1- than for beta 2-adrenoceptors.[Abstract] [Full Text] [Related] [New Search]